Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of the Pharmacokinetics and Immunologic Effects of Lipoic Acid in Multiple Sclerosis

This study has been completed.
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Vijayshree Yadav, Oregon Health and Science University Identifier:
First received: May 7, 2008
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)